Physician

Joshua A Morales, MD

According to 2025 Medicare claims, Joshua Morales, MD (NPI: 1063731016) practices hematology/oncology in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Bedford, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24014-2419.

Morales' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 610 traditional Medicare patients, billed 109,444 HCPCS/CPT codes, and received $2,460,344 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,406 prescription claims across 230 beneficiaries totaling $4,557,960 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 30 claims. Open Payments data shows 1 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $483,902 to $2,460,344. Similarly, Part D prescription costs have risen steadily, from $221,976 to $4,557,960. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2017 Medicare payment: $483,902 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,216,817 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,625,071 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,939,768 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,433,011 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,445,522 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,197,540 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,460,344 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201727620,399$483,902
201865991,709$1,216,817
2019650122,588$1,625,071
2020658117,325$1,939,768
2021671144,675$2,433,011
2022657130,096$2,445,522
2023646121,135$2,197,540
2024610109,444$2,460,344

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.6M2015 Drug cost: $221,976 (USD; Tot_Drug_Cst)2016 Drug cost: $205,876 (USD; Tot_Drug_Cst)2017 Drug cost: $60,280 (USD; Tot_Drug_Cst)2018 Drug cost: $541,614 (USD; Tot_Drug_Cst)2019 Drug cost: $1,374,898 (USD; Tot_Drug_Cst)2020 Drug cost: $2,474,040 (USD; Tot_Drug_Cst)2021 Drug cost: $3,635,874 (USD; Tot_Drug_Cst)2022 Drug cost: $3,132,364 (USD; Tot_Drug_Cst)2023 Drug cost: $3,106,089 (USD; Tot_Drug_Cst)2024 Drug cost: $4,557,960 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201522129$221,976
20161468$205,876
201730126$60,280
2018118667$541,614
20191461,008$1,374,898
20201581,119$2,474,040
20211791,033$3,635,874
20221951,286$3,132,364
20232031,302$3,106,089
20242301,406$4,557,960

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.9K$14K2019 Medicare payment: $10,123 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $13,601 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $13,533 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $6,915 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $13,835 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $784 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201932105$10,123
202060174$13,601
202165193$13,533
202248178$6,915
20232888$13,835
2024N/R30$784

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more149289$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more231360$63
80053Blood test, comprehensive group of blood chemicals187785$10
36415Insertion of needle into vein for collection of blood sample232624$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2741,227$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide591,624$749,353
RevlimidLenalidomide27749$565,457
BrukinsaZanubrutinib27810$408,284
ImbruvicaIbrutinib21588$343,949
CalquenceAcalabrutinib Maleate27810$314,131

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R16$539
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$245

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$33Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua A. Morales, MD?

Tedicare shows public-source Medicare data for Joshua A. Morales, MD (NPI 1063731016), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua A. Morales, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua A. Morales, MD?

Joshua A. Morales, MD is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does Joshua A. Morales, MD have Open Payments data?

Joshua A. Morales, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.